On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.
More Latest News
December 27, 2018
Please click here for more information regarding extended license expiration deadlines for Registered Pharmacy Technician and Consultant Pharmacist. Continue reading
November 1, 2018
The Annual Report & Long-Range Plan for the 2017-2018 Fiscal Year is now available to view online. Continue reading